| Style | Citing Format | 
|---|---|
| MLA | Razi F, Nasliesfahani E, Bandarian F. "Association of Serum Uric Acid With Nephropathy in Iranian Type 2 Diabetic Patients." Journal of Diabetes and Metabolic Disorders, vol. 17, no. 1, 2018, pp. 71-75. | 
| APA | Razi F, Nasliesfahani E, Bandarian F (2018). Association of Serum Uric Acid With Nephropathy in Iranian Type 2 Diabetic Patients. Journal of Diabetes and Metabolic Disorders, 17(1), 71-75. | 
| Chicago | Razi F, Nasliesfahani E, Bandarian F. "Association of Serum Uric Acid With Nephropathy in Iranian Type 2 Diabetic Patients." Journal of Diabetes and Metabolic Disorders 17, no. 1 (2018): 71-75. | 
| Harvard | Razi F, Nasliesfahani E, Bandarian F (2018) 'Association of Serum Uric Acid With Nephropathy in Iranian Type 2 Diabetic Patients', Journal of Diabetes and Metabolic Disorders, 17(1), pp. 71-75. | 
| Vancouver | Razi F, Nasliesfahani E, Bandarian F. Association of Serum Uric Acid With Nephropathy in Iranian Type 2 Diabetic Patients. Journal of Diabetes and Metabolic Disorders. 2018;17(1):71-75. | 
| BibTex | @article{ author = {Razi F and Nasliesfahani E and Bandarian F}, title = {Association of Serum Uric Acid With Nephropathy in Iranian Type 2 Diabetic Patients}, journal = {Journal of Diabetes and Metabolic Disorders}, volume = {17}, number = {1}, pages = {71-75}, year = {2018} } | 
| RIS | TY  - JOUR AU - Razi F AU - Nasliesfahani E AU - Bandarian F TI - Association of Serum Uric Acid With Nephropathy in Iranian Type 2 Diabetic Patients JO - Journal of Diabetes and Metabolic Disorders VL - 17 IS - 1 SP - 71 EP - 75 PY - 2018 ER -  |